Renoprotective effects of combining ACE inhibitors and statins in experimental diabetic rats

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 5, 2011, Pages 322-325

  Mudagal, M ^a   Patel, J ^a   Nagalakshmi, N C ^a   Asif Ansari, M ^a  

^a ACHARYA AND B M REDDY COLLEGE OF PHARMACY   (India)

Author keywords

Atorvastatin; Diabetic nephropathy; Telmisartan

Indexed keywords

ALBUMIN; ATORVASTATIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOZOCIN; TELMISARTAN; TRIACYLGLYCEROL; UREA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HISTOPATHOLOGY; MALE; MICROALBUMINURIA; MONOTHERAPY; NONHUMAN; PROTEIN ANALYSIS; PROTEINURIA; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 84455199548     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sally ET, Susan V, Paul DK, Scott JH. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J Diabetes Complicat, 2008;22:284-294.
2. Sung IL, Dong CH. Lovastatin transforming growth factor-β 1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am SocNephrol, 2000;11:80-87.
3. Noriko U, Yumiko S, Masanobu T. Association between plasma oxidized low density lipoprotein and diabetic nephropathy. Diabetes Res ClinPract, 2002;58:109-114.
4. Lawrence AL. The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering? Diabetes Res Clin Pract,2005;68:03-14.
5. Masaomi N, Toshio M, Toshio S. Anti hypertensive agents inhibit in vivo the formation of advance glycation end product and improve renal damage in a type 2 diabetic nephropathy rat model. J Am SocNephrol, 2003;14:1212-1222.
6. Dilek Y, Belgin K, Goncagul H, Onder E. Effect of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney. Plefa, 2003;69:223-227.
7. David JE, Ashok KS, Joseph PB. Glomerular renin angiotensin system in streptozotocin diabetic and zucker diabetic fatty rats. Transl Res, 2008;151:208-216.
8. Carla Z, Daniela C, Dario C. Effect of combinig ACE inhibitor and statin in severe experimental nephropathy. Kidney Int, 2002;61:1635-1645.
9. Jie Q, Zhili Z, Jie L, Liao S. Effect of the combination of an angiotensin II antagonist with an HMG CoA reductase inhibitor in experimental diabetes. Kidney Int, 2003;64:565-571.
10. Richa V, Harbans L, Singh J. Biochemical effect of irbesartan in experimental diabetic nephropathy. Indian J Pharmacol, 2009;41:252-254.
11. Karin JD, Zemin C, Alison J, Darren J. Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathy. Kidney Int, 1999;56:31-36.